Is clindamycin safe to use during pregnancy for bacterial vaginosis, and is metronidazole an appropriate alternative for a woman who is not planning pregnancy but had recent unprotected intercourse?

Treatment of Bacterial Vaginosis in Pregnancy

Both oral clindamycin (300 mg twice daily for 7 days) and oral metronidazole (250 mg three times daily for 7 days) are safe and acceptable options for treating BV during pregnancy, with metronidazole being the preferred first-line agent. Given your recent unprotected intercourse and uncertain pregnancy status, you should take a pregnancy test first, but either medication can be safely used if you are pregnant.

Key Treatment Recommendations

For Confirmed or Suspected Pregnancy:

Metronidazole is the recommended first-line treatment 1, 2:

• Preferred regimen: Metronidazole 250 mg orally three times daily for 7 days
• Alternative regimen: Clindamycin 300 mg orally twice daily for 7 days

Both medications are explicitly listed as safe options during pregnancy in CDC guidelines 1, 2. The lower metronidazole dose (250 mg vs. the standard 500 mg used in non-pregnant women) is specifically recommended to minimize fetal exposure while maintaining efficacy.

Important Safety Considerations:

Metronidazole safety profile 1, 3:

• Multiple studies and meta-analyses have NOT demonstrated consistent teratogenic or mutagenic effects in human newborns
• Crosses the placental barrier but reproduction studies show no evidence of harm to the fetus
• FDA Pregnancy Category B
• Can be used throughout pregnancy, including early pregnancy

Clindamycin safety profile 4:

• Systemic (oral) clindamycin during second and third trimesters has not been associated with increased congenital abnormalities
• Should be used in first trimester only if clearly needed, though no evidence of teratogenicity exists
• Critical caveat: Clindamycin vaginal cream is NOT recommended in pregnancy due to two randomized trials showing increased preterm deliveries 1

Clinical Decision Algorithm:

1. Take a pregnancy test immediately given recent unprotected intercourse
2. If pregnant or pregnancy cannot be ruled out:
   • Start metronidazole 250 mg orally three times daily for 7 days (preferred)
   • OR clindamycin 300 mg orally twice daily for 7 days (acceptable alternative)
3. Avoid: Metronidazole 2g single dose (lower efficacy), clindamycin vaginal cream (increased preterm delivery risk), metronidazole vaginal gel (limited pregnancy data)

Why Treatment Matters in Pregnancy:

BV during pregnancy is associated with serious adverse outcomes 1, 2:

• Premature rupture of membranes
• Preterm labor and delivery
• Chorioamnionitis
• Postpartum endometritis
• Post-cesarean wound infection

Treating symptomatic BV in pregnancy reduces these risks and relieves symptoms, making treatment clearly beneficial regardless of pregnancy risk status.

Practical Points:

• With metronidazole: Avoid alcohol during treatment and for 24 hours after completion
• Systemic (oral) therapy is preferred over vaginal preparations during pregnancy to treat possible subclinical upper genital tract infections 1
• No need to treat sexual partners (does not affect cure rates or recurrence) 1
• If high-risk for preterm delivery (prior premature infant), consider follow-up evaluation 1 month after treatment 1

Bottom line: Don't delay treatment while waiting for pregnancy confirmation. Both oral metronidazole and oral clindamycin are safe options, with metronidazole being the guideline-recommended first choice. The benefits of treating BV clearly outweigh any theoretical risks during pregnancy.